Article By:
Taki Tsaklanos
Thursday, October 6, 2016 4:00 AM EDT
One of the very promising biotech companies which we covered in May of this year is Advaxis. It is a small cap with a $467M market cap with a potential solution to weaken cancer.
In this article: ADXS